About: Potential applications of plant biotechnology against SARS-CoV-2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Potential applications of plant biotechnology against SARS-CoV-2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Potential applications of plant biotechnology against SARS-CoV-2
Creator	Capell, Teresa Christou, Paul Ma, -C Schillberg, Stefan Armario-Najera, Victoria Ma, Julian K-C Twyman, Richard
source	Elsevier; Medline; PMC
abstract	Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for an ongoing human pandemic (COVID-19). There is a massive international effort underway to develop diagnostic reagents, vaccines and antiviral drugs in a bid to slow down the spread of the disease and save lives. One part of that international effort involves the research community working with plants, bringing researchers from all over the world together with commercial enterprises in order to achieve the rapid supply of protein antigens and antibodies for diagnostic kits, and scalable production systems for the emergency manufacturing of vaccines and antiviral drugs. Here we look at some of the ways in which plants can and are being used in the fight against COVID-19.
has issue date	2020-04-24(xsd:dateTime)
bibo:doi	10.1016/j.tplants.2020.04.009
bibo:pmid	32371057
has license	els-covid
sha1sum (hex)	fcb8817ba5d6db3a34d87b15258715c9baa9b4f1
schema:url	https://doi.org/10.1016/j.tplants.2020.04.009
resource representing a document's title	Potential applications of plant biotechnology against SARS-CoV-2
has PubMed Central identifier	PMC7181989
has PubMed identifier	32371057
schema:publication	Trends in plant science
resource representing a document's body	covid:fcb8817ba5d6db3a34d87b15258715c9baa9b4f1#body_text
is schema:about of	named entity 'Journal' named entity 'biotechnology' named entity 'Potential' named entity 'SARS-CoV-2' named entity 'biotechnology' named entity 'plant biotechnology' named entity 'plant biotechnology' named entity 'SARS-CoV-2' named entity 'swine' named entity 'receptor' named entity 'T-cell' named entity 'antibodies' named entity 'SARS-CoV-2' named entity 'molecular farming' named entity 'vaccine' named entity 'cytokine storm' named entity 'T-DNA' named entity 'humoral responses' named entity 'antibody' named entity 'coronaviruses' named entity 'serum' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'griffithsin' named entity 'pandemic disease' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'Arabidopsis thaliana' named entity 'mannose' named entity 'HIV' named entity 'therapeutic proteins' named entity 'protein' named entity 'SARS-CoV-2' named entity 'molecular farming' named entity 'tocilizumab' named entity 'transgenic crops' named entity 'antibodies' named entity 'pathogen' named entity 'COVID' named entity 'clinical trials' named entity 'vaccine' named entity 'vaccine' named entity 'DNA synthesis' named entity 'Zaire ebolavirus' named entity 'positive control' named entity 'epithelial cells' named entity 'SARS-CoV' named entity 'lectin' named entity 'COVID-19' named entity 'virus particle' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'SARS-CoV' named entity 'sugar residues' named entity 'ACE2' named entity 'recombinant' named entity 'viruses' named entity 'lyse' named entity 'nucleocapsid' named entity 'therapeutic window' named entity 'vaccine' named entity 'Tobacco mosaic virus' named entity 'virus' named entity 'neutralizing antibody' named entity 'prophylaxis' named entity 'virus' named entity 'microbes' named entity 'genome' named entity 'Spike protein' named entity 'SARS-CoV-2' named entity 'protein' named entity 'transgenic plants' named entity 'Griffithsin' named entity 'antibodies' named entity 'mannose'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software